Abietic Acid

CAS No. 514-10-3

Abietic Acid( 2-ODA )

Catalog No. M18697 CAS No. 514-10-3

Abietic Acid is the primary component of resin acid isolated from rosin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Abietic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Abietic Acid is the primary component of resin acid isolated from rosin.
  • Description
    2-ODA inhibitor of Plasmodium infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2-ODA
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    MMP-1| PPARα| PPARγ
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    514-10-3
  • Formula Weight
    302.45
  • Molecular Formula
    C20H30O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (330.63 mM)
  • SMILES
    CC(C)C1=CC2=CC[C@@H]3[C@@]([C@H]2CC1)(CCC[C@@]3(C)C(=O)O)C
  • Chemical Name
    2-Octadecynoic Acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jeon Y, et al. Exp Dermatol. 2015 Feb;24(2):140-5.
molnova catalog
related products
  • Margaritene

    Margaritene is a natural product for research related to life sciences.

  • 1-Cinnamoylpyrrolidi...

    1-Cinnamoylpyrrolidine, a natural product prepared from Piper caninum, can be used as a DNA strand breaking agent, inducing the relaxation of the plasmid pBR322 DNA superhelix in the presence of Cu2+. 1-Cinnamoylpyrrolidine inhibits PAF-induced platelet aggregation with an IC50 value of 37.3 μM. value was 37.3 μM.

  • trans-2-Butene-14-di...

    3-Hexenedioic acid is a normal human unsaturated dicarboxylic acid metabolite with increased excretion in patients with Dicarboxylic aciduria caused by fatty acid metabolism disorders The urinary excretion of 3-Hexenedioic acid is increased in conditions of augmented mobilization of fatty acids or inhibited fatty acid oxidation.